SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019294
Filing Date
2018-08-06
Accepted
2018-08-06 09:13:26
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-10q_20180630.htm 10-Q 1088536
2 EX-31.1 krys-ex311_6.htm EX-31.1 23529
3 EX-31.2 krys-ex312_8.htm EX-31.2 24130
4 EX-32.1 krys-ex321_7.htm EX-32.1 24327
  Complete submission text file 0001564590-18-019294.txt   4717544

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krys-20180630.xml EX-101.INS 1070811
6 XBRL TAXONOMY EXTENSION SCHEMA krys-20180630.xsd EX-101.SCH 36514
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krys-20180630_cal.xml EX-101.CAL 30107
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krys-20180630_def.xml EX-101.DEF 101262
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20180630_lab.xml EX-101.LAB 277817
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20180630_pre.xml EX-101.PRE 220486
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 18993602
SIC: 2836 Biological Products, (No Diagnostic Substances)